Name: Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry (Video) | JoVE Journal
Uploaded: 2015-11-04T15:00:00.000+00:00
Duration: 7 min 25 s
Description: Learn to measure influenza A virus attachment and internalization in A549 lung epithelial cells using flow cytometry. This protocol uses cold binding, temperature shift, and blocking steps to distinguish attached from internalized viral particles.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by a grant from the Swiss National Science Foundation (31003A_135278) to SSt. MOP is the beneficiary of a doctoral grant from the AXA Research Fund. We thank Patricia Nigg for help with the design of Figure 1.

Note before start: Use laminar flow hood and appropriate biocontainment when working with live virus. Here, we describe growth conditions suitable to culture influenza virus strain A/WSN/33. Multiplicity of infection (MOI) and incubation times may vary depending on virus strain used.
1. Preparation of Biotinylated A/WSN/33 Virus
<ol>
	<li>Seed Madin-Darby canine kindey (MDCK) cells into a T175 cm2 flask using Dulbecco&#8217;s Modified Eagle Medium (DMEM) supplemented with 10% FBS and 1% penicillin-streptomycin (Pen/Strep). Culture cells at 37 &#176;C until approximately 70% confluency is reached.</li>
	<li>Before infection, remove medium and wash cells with phosphate-buffered saline (PBS, pH7.0-7.3) by adding a large enough volume to cover the cell monolayer.</li>
	<li>Remove PBS and infect cells with A/WSN/33 with an MOI of 10-4. Dilute virus in PBS supplemented with 0.02 mg Mg2+, 0.01 mg Ca2+, 0.3% bovine serum albumin (BSA), and 1% Pen/Strep (infection-PBS). Use an inoculum of 4 ml for a T175 cm2 flask.</li>
	<li>Incubate cells 1 hr at 37 &#176;C. Remove inoculum by aspiration and pipette 10 ml DMEM supplemented with 0.3% BSA, 20 mM HEPES, and 1% Pen/Strep into the flask.</li>
	<li>Incubate cells at 37 &#176;C for approximately 3 days until cytopathic effect (CPE) is visible, and then harvest supernatant. CPE can be recognized as rounding up of cells followed by detachment and death of cells 14.</li>
	<li>Spin supernatant at 450 x g for 5 min to remove cell debris. Transfer supernatant into a new falcon tube and repeat this step one more time. Discard the pellets.</li>
	<li>Transfer supernatants into ultracentrifuge tubes and underlay supernatants with 5 ml of 30% sucrose diluted in NTE buffer (10 mM Tris [pH 7.4], 100 mM NaCl, 1 mM EDTA). Balance tubes before ultracentrifugation and fill up with PBS to reach an end volume of 30 ml. Spin supernatants at 112,398 x g (corresponding to 25,000 rpm for an SW28 rotor) for 90 min in an ultracentrifuge.</li>
	<li>Carefully remove supernatant by pipetting and soak virus pellet overnight at 4 &#176;C in 250 &#181;l PBS. Resuspend pellet by pipetting up and down. Measure protein content of purified virus by Bradford assay 15.</li>
	<li>Use a biotinylation kit to generate biotinylated A/WSN/33. Follow the instruction of the manufacturer.</li>
	<li>In brief, add the appropriate amount of biotin to the purified virus and incubate for 2h on ice. Transfer virus to an ultracentrifuge tube and fill tube up with PBS to reach an end volume of 30 ml. Spin virus at 112,389 xg for 90 min in an ultracentrifuge. Remove supernatant by pipetting and add 250 &#181;l PBS. Soak pellet over night at 4 &#176;C. Aliquot and store the Biotinylated virus stored at -80 &#176;C where it will be stable for at least 24 months. 
	NOTE: It might be helpful to determine the titer of the biotinylated preparation of IAV by standard plaque assay. However, it should be noted that the subsequent protocol will only measure biotinylated virus particles. Remaining unbiotinylated particles due to incomplete biotinylation will contribute to the infectious titer by plaque assay but not to the signal measured in the attachment/internalization assay.</li>
</ol>
2. Determine the Required Amount of Biotinylated Virus &#160;
NOTE: Before the attachment/internalization assay is performed, it is important to determine the amount of biotinylated virus required to infect all cells of a sample.
<ol>
	<li>Culture and trypsinize A549 cells according to the manufacturer&#8217;s instructions. Count the cells using a cell chamber. Pipette 200,000 A549 cells into FACS deepwell tubes. Spin 3 min at 450 x g. Remove supernatant and resuspend pellet with 200 &#181;l PBS. Cool cells down on ice for 10 min.</li>
	<li>Prepare 5-fold serial dilutions of the biotinylated virus stock in infection-PBS.</li>
	<li>Spin tubes containing the cells at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet with 100 &#181;l virus-containing infection-PBS. As mock control use infection-PBS without biotinylated virus. Incubate tubes on ice for 1 hr.</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l PBS. Repeat this step one more time.</li>
	<li>For fixation, spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 100 &#181;l of 3.7% paraformaldehyde (PFA). Incubate for 10 min at RT. Then, repeat wash step described in 2.4).</li>
	<li>For permeabilization, spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 100 &#181;l PBS containing 0.5% Triton X-100. Incubate for 6 min at RT. Then, repeat wash step described in 2.4).</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 50 &#181;l 2% BSA diluted in PBS containing STV-Cy3. (Please note, the appropriate concentration of STV-Cy3 should be determined before starting the experiment. Start with a concentration of 1:200 and test 2-fold dilutions up to 1:2,400. In our hands, a dilution of 1:1,000 proved to be optimal.)</li>
	<li>Incubate 1 hr in the dark at RT. Then, repeat washing step described in 2.4 but resuspend the pellet in 200 &#181;l 2% BSA diluted in PBS.</li>
	<li>Analyze samples by flow cytometry 16. Gate on the Cy3-positive population. Choose the lowest concentration of biotinylated virus resulting in the maximum number of Cy3-positive cells in the A549 population.</li>
</ol>
3. Determine the Required Amount of Streptavidin
 
NOTE: The efficiency of blocking the signal derived from extracellular virus determines the detection range of the assay. Therefore, it is important to abrogate the STV-Cy3 signal as much as possible. The required amount of STV needed depends on the amount of biotinylated virus stock used (determined in section 2).
<ol>
	<li>Follow steps 2.1-2.4, but use virus concentration determined in section 2.</li>
	<li>Prepare five-fold serial dilutions of STV diluted in PBS containing 2% BSA and 0.1% sodium azide.</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 50 &#181;l STV dilution. As mock control use PBS containing 2% BSA and 0.1% sodium azide without STV. Incubate tubes for 30 min on ice. Then, repeat wash step described in 2.4.</li>
	<li>Follow steps 2.5-2.9. For the internalization assay, choose the lowest concentration of STV resulting in a strong block of the Cy3-signal (compared to the sample in which no STV was present). For this, the percentage of CY3-positive cells or the mean fluorescence intensity of the Cy3 signal can be used. Ideally, the Cy3 signal of STV-treated samples should be as close to the signal from mock-infected cells as possible.</li>
</ol>
4. Attachment/Internalization Assay
 
NOTE: Make sure to prepare all reagents before starting the assay. For the three control groups presented in the results section (mock infected cells, neuraminidase pre-treated cells and sodium azide treated cells) small alterations to the protocol are required.
<ol>
	<li>Prepare 16 deepwell tubes each containing 200,000 A549 cells. Next to the experimental set consisting of 4 tubes, there are 3 control conditions, each requiring 4 tubes: mock-infected cells, neuraminidase (NA)-pretreated cells and sodium azide-treated cells. Each group consists of 4 tubes labelled as &#8216;0 min&#8217;, &#8216;0 min + STV&#8217;, &#8216;30 min&#8217;, &#8216;30 min + STV&#8217;.</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l PBS.</li>
	<li>Spin tubes at 4 &#176;C at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l DMEM containing 0.3% BSA, 20 mM HEPES and 1% penicillin-streptomycin (incubation medium). Incubate for 30 min at 37 &#176;C. 
	NOTE: For the neuraminidase control: Use bacterial neuraminidase (e.g. sialidase from Vibrio cholera) at a concentration of 200 mU/ml diluted in incubation medium to resuspend the cells.</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l PBS. Repeat this step one more time, then cool tubes down on ice for 10 min.</li>
	<li>Spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 100 &#181;l biotinylated virus (use the virus concentration determined in section 2 diluted in infection-PBS). Incubate 1 hr on ice. Then, repeat wash step described in 2.4. 
	NOTE: For the mock-infected control: Use infection-PBS without virus. For the sodium azide control: Use virus diluted in infection-PBS supplemented with 0.1 % sodium azide.</li>
	<li>Processing of the samples after the infection on ice:
	<ol>
		<li>For the &#8216;0 min&#8217; samples, follow step 2.5 and store samples at 4 &#176;C until the other samples are fixed.</li>
		<li>For the &#8216;0 min + STV&#8217; samples, spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 50 &#181;l STV (use the concentration determined in section 3) diluted in PBS containing 2% BSA and 0.1% sodium azide (to prevent internalization while handling the sample). Incubate 30 min on ice. Follow step 2.4-2.5 and store samples at 4 &#176;C.</li>
		<li>For the &#8217;30 min&#8217; samples, spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l PBS containing 2% BSA. Incubate 30 min at 37 &#176;C. Follow step 2.4-2.5 and store samples at 4 &#176;C. 
		NOTE: For the sodium azide control: Use PBS supplemented with 2 % BSA and 0.1 % sodium azide for the 30 min incubation at 37 &#176;C.</li>
		<li>For the &#8217;30 min + STV&#8217; samples spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 200 &#181;l PBS containing 2% BSA. Incubate 30 min at 37 &#176;C. Then, spin tubes at 4 &#176;C for 3 min at 450 x g. Remove supernatant and resuspend pellet in 50 &#181;l STV (use the concentration determined in section 3) diluted in PBS containing 2% BSA and 0.1% sodium azide (to prevent internalization while handling the sample). Incubate 30 min on ice. Follow step 2.4-2.5 and store samples at 4 &#176;C. 
		NOTE: For the sodium azide control: Use PBS supplemented with 2 % BSA and 0.1 % sodium azide for the 30 min incubation at 37 &#176;C.</li>
	</ol>
	</li>
	<li>Follow steps 2.6-2.8 and analyze samples by flow cytometry. Determine the percentage of Cy3-positive cells in each sample.</li>
	<li>Calculate the percentage attached virus and the relative amount of internalized virus.
	<ol>
		<li>To calculate the amount of attached virus, use the percentage of Cy3-positive gated cells or the mean fluorescence intensity of the Cy3 signal. For comparison, set untreated cells to 100 % (Figure 4B). 
		NOTE: The percentage of attached virus is described by the &#8220;0 min&#8221; sample.</li>
		<li>To calculate the amount of internalized virus, take the ratio of the &#8220;30 min + STV&#8221; sample to the &#8220;30 min&#8221; sample (Figure 5B). 
		NOTE: As mentioned above, the percentage of Cy3 positive gated cells or the mean fluorescence intensity of the Cy3 signal can be used.</li>
	</ol>
	</li>
</ol>

<ol><li>Edinger, T. O., Pohl, M. O., Stertz, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Entry+of+influenza+A+virus%3A+host+factors+and+antiviral+targets%5BTitle%5D)+AND+%22J+Gen+Virol%22%5BJournal%5D)">Entry of influenza A virus: host factors and antiviral targets.</a> J Gen Virol. 95, 263-277 (2014).</li>
<li>Palese, P., Shaw, M. L. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aPalese%2C+P+%22Fields+Virolog%22">Fields Virolog</a>. Knipe, D. M., Howley, P. M. 2, Lippincott Williams and Wilkins. (2007).</li>
<li>Matlin, K. S., Reggio, H., Helenius, A., Simons, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Infectious+entry+pathway+of+influenza+virus+in+a+canine+kidney+cell+line%5BTitle%5D)+AND+%22J+Cell+Biol%22%5BJournal%5D)">Infectious entry pathway of influenza virus in a canine kidney cell line.</a> J Cell Biol. 91, 601-613 (1981).</li>
<li>Sieczkarski, S. B., Whittaker, G. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Influenza+virus+can+enter+and+infect+cells+in+the+absence+of+clathrin-mediated+endocytosis%5BTitle%5D)+AND+%22J+Virol%22%5BJournal%5D)">Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis.</a> J Virol. 76, 10455-10464 (2002).</li>
<li>Rust, M. J., Lakadamyali, M., Zhang, F., Zhuang, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assembly+of+endocytic+machinery+around+individual+influenza+viruses+during+viral+entry%5BTitle%5D)+AND+%22Nat+Struct+Mol+Biol%22%5BJournal%5D)">Assembly of endocytic machinery around individual influenza viruses during viral entry.</a> Nat Struct Mol Biol. 11, 567-573 (2004).</li>
<li>Vries, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dissection+of+the+influenza+A+virus+endocytic+routes+reveals+macropinocytosis+as+an+alternative+entry+pathway%5BTitle%5D)+AND+%22PLoS+Pathog%22%5BJournal%5D)">Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway.</a> PLoS Pathog. 7, e1001329(2011).</li>
<li>Vries, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Influenza+A+virus+entry+into+cells+lacking+sialylated+N-glycans%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+USA%22%5BJournal%5D)">Influenza A virus entry into cells lacking sialylated N-glycans.</a> Proc Natl Acad Sci USA. 109, 7457-7462 (2012).</li>
<li>Londrigan, S. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((N-linked+glycosylation+facilitates+sialic+acid-independent+attachment+and+entry+of+influenza+A+viruses+into+cells+expressing+DC-SIGN+or+L-SIGN%5BTitle%5D)+AND+%22J+Virol%22%5BJournal%5D)">N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN.</a> J Virol. 85, 2990-3000 (2011).</li>
<li>Wang, S. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((DC-SIGN+mediates+avian+H5N1+influenza+virus+infection+in+cis+and+in+trans%5BTitle%5D)+AND+%22Biochem+Biophys+Res+Commun%22%5BJournal%5D)">DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans.</a> Biochem Biophys Res Commun. 373, 561-566 (2008).</li>
<li>Pohl, M. O., Edinger, T. O., Stertz, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Prolidase+is+required+for+early+trafficking+events+during+influenza+A+virus+entry%5BTitle%5D)+AND+%22J+Virol%22%5BJournal%5D)">Prolidase is required for early trafficking events during influenza A virus entry.</a> J Virol. 88, 11271-11283 (2014).</li>
<li>Konig, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+host+factors+required+for+influenza+virus+replication%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Human host factors required for influenza virus replication.</a> Nature. 463, 813-817 (2010).</li>
<li>Ludwig, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+cell+signalling+pathways+to+fight+the+flu%3A+towards+a+paradigm+change+in+anti-influenza+therapy%5BTitle%5D)+AND+%22J+Antimicrob+Chemothe%22%5BJournal%5D)">Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.</a> J Antimicrob Chemothe. 64, 1-4 (2009).</li>
<li>Simoes, S., Slepushkin, V., Duzgunes, N., Pedroso de Lima, M. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((On+the+mechanisms+of+internalization+and+intracellular+delivery+mediated+by+pH-sensitive+liposomes%5BTitle%5D)+AND+%22Biochim+Biophys+Acta%22%5BJournal%5D)">On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes.</a> Biochim Biophys Acta. 1515, 23-37 (2001).</li>
<li>Tran, A. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Knockdown+of+specific+host+factors+protects+against+influenza+virus-induced+cell+death%5BTitle%5D)+AND+%22Cell+death%2C+and+disease%22%5BJournal%5D)">Knockdown of specific host factors protects against influenza virus-induced cell death.</a> Cell death, and disease. 4, e769(2013).</li>
<li>Bradford, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+rapid+and+sensitive+method+for+the+quantitation+of+microgramm+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding%5BTitle%5D)+AND+%22Anal+Biochem%22%5BJournal%5D)">A rapid and sensitive method for the quantitation of microgramm quantities of protein utilizing the principle of protein-dye binding.</a> Anal Biochem. 72, 248-254 (1976).</li>
<li>Macey, M. G. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aMacey%2C+MG+%22Flow+Cytometry+Principles+and+Applications%22">Flow Cytometry Principles and Applications</a>. Macey, M. G. , Humana Press. (2007).</li>
<li>Burness, A. T., Pardoe, I. U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effect+of+enzymes+on+the+attachment+of+influenza+and+encephalomyocarditis+viruses+to+erythrocytes%5BTitle%5D)+AND+%22J+Gen+Viro%22%5BJournal%5D)">Effect of enzymes on the attachment of influenza and encephalomyocarditis viruses to erythrocytes.</a> J Gen Viro. 55, 275-288 (1981).</li>
</ol>

The authors have nothing to disclose.

Our protocol describes an easy way of measuring virus attachment and internalization by flow cytometry. It allows the use of labeled wildtype virus which mimics more closely virus infections compared to the use of virus-like particles (VLP). While our protocol has been optimized to measure attachment and internalization of IAV it can easily be adapted for other viruses. In addition, as flow cytometry is used for readout, co-stainings can be easily added to the protocol e.g. to test expression levels following kn...

The entry of influenza A virus (IAV) is a multi-step process that starts with the binding of the virus to receptors on the plasma membrane of target cells 1. The receptor for IAV is sialic acid which is present on a large variety of glycoproteins and glycolipids. The hemagglutinin (HA) protein of IAV which is present in the viral envelope binds to sialic acid and thereby mediates attachment of the viral particles to the plasma membrane of target cells 2. The virus enters the cells via clathrin-mediated endocytosis but also alternative entry pathways, such as macropinocytosis, have been described 3-6. The interaction between HA and sialic acid appears to be sufficient for mediating both, attachment and triggering internalization of viral particles 7. Nevertheless, alternative entry receptors have been proposed and their roles in IAV entry are currently being investigated 1,8,9.
Currently, efforts are made to identify host factors that are involved in the viral life cycle with the aim of developing urgently needed novel antiviral therapies 10-12. Virus entry would be a favorable step for targeting IAV growth in order to block viral infection at its earliest point. Measuring different stages of IAV entry experimentally is challenging as usually large amounts of virus are required to detect incoming virus. In addition, the detection range for changes in virus entry is only linear due to the lack of viral replication. This underscores the need for assays with high sensitivity.
The assay we present here allows the detection of attached virus at the cell surface as well as detection of internalized virus in relation to the total amount of cell-associated virus. The use of biotinylated wildtype virus enables convenient measurement through staining with STV-Cy3 and readout by flow cytometry. Biotinylated virus is cold-bound to cells to allow attachment but prevent internalization of viral particles. Cells can be fixed, permeabilized and stained with STV-Cy3 to measure attached virus. The signal from extracellular, attached virions can be abrogated if a blocking step is applied before fixation in which the cells are incubated with non-labeled streptavidin (STV). In a next step, following attachment of biotinylated IAV, temperature is shifted to 37 &#176;C and internalization of viral particles is allowed to take place. Internalized particles are protected from binding of STV thereby allowing the discrimination between extra- and intracellular viruses.
Per experimental condition, four samples are required: &#8216;0 min&#8217;: The first sample, labeled &#8216;0 min&#8217;, is to measure cold-bound virus at the cell surface. &#8216;0 min + STV&#8217;: The second sample, labeled &#8216;0 min + STV&#8217;, gives the baseline signal intensity of the experiment. Attached virus is blocked with STV and the signal following staining with STV-Cy3 should be much lower compared to the &#8216;0 min&#8217; sample. &#8217;30 min&#8217;: The third sample, &#8217;30 min&#8217; contains attached and internalized virus due to the temperature shift to 37 &#176;C for 30 min. &#8217;30 min + STV&#8217;: The fourth sample, &#8217;30 min + STV&#8217; measures the intracellular fraction of viruses. The STV blocking step is applied after the 30 min incubation period. As a result, viral particles at the cell surface are bound by STV leaving only internalized viruses available for staining with STV-Cy3. The relative amount of internalized virus can be calculated as the ratio of internalized virus (measured in the &#8217;30 min + STV&#8217; sample) divided by the total amount of virus (described by the &#8217;30 min&#8217; sample).
As controls we suggest to include mock-infected cells. The signal following STV-Cy3 staining of mock-infected cells gives the background resulting from the staining protocol. A control for IAV attachment is the pre-treatment of cells with bacterial neuraminidase (NA). NA cleaves off sialic acid from cellular glycoproteins, thereby removing attachment receptors from the cell surface. Sodium azide (SA) is a potent metabolic inhibitor and thereby blocks endocytosis 13. Cells treated with sodium azide should be positive for virus binding but negative for internalization.

<table><tbody><tr><td>DMEM</td><td>Life Technologies</td><td>41966-052</td><td></td></tr><tr><td>FBS</td><td>Life Technologies</td><td>10270-106</td><td></td></tr><tr><td>Penicillin-Streptomycin</td><td>Life Technologies</td><td>15140-163</td><td></td></tr><tr><td>PBS</td><td>Life Technologies</td><td>14190-169&amp;nbsp;&amp;nbsp;</td><td></td></tr><tr><td>BSA</td><td>VWR Calbiochem</td><td>126579</td><td></td></tr><tr><td>HEPES</td><td>Life Technologies</td><td>15630-100</td><td></td></tr><tr><td>D-Sucrose</td><td>Fluka</td><td>84100</td><td></td></tr><tr><td>TRIS</td><td>Biosolve BV</td><td>20092391</td><td></td></tr><tr><td>EDTA</td><td>Sigma-Aldrich</td><td>3680</td><td></td></tr><tr><td>EZ-LINK NHS-SS-BIOTIN kit</td><td>Fisher Scientific</td><td>&lt;a href=&quot;https://extranet.fisher.co.uk/insight2_ch/getProduct.do?productCode=W9971E&quot;&gt;W9971E&amp;nbsp;&lt;/a&gt;</td><td></td></tr><tr><td>Bio Rad Protein Bio Assay</td><td>Bio Rad</td><td>500-0006</td><td></td></tr><tr><td>deepwell tubes (1.2 ml microtubes)</td><td>Milian</td><td>82 00 001</td><td></td></tr><tr><td>PFA</td><td>&amp;nbsp;Lucerna chem&amp;nbsp; Electron microscopy sciences</td><td>15710</td><td></td></tr><tr><td>ultracentrifuge tubes</td><td>Hemotec HmbH</td><td>253070</td><td></td></tr><tr><td>Triton X-100</td><td>Fluka</td><td>93420</td><td></td></tr><tr><td>STV-Cy3</td><td>Life Technologies</td><td>43-4315</td><td></td></tr><tr><td>STV</td><td>Life Technologies</td><td>43-4302</td><td></td></tr><tr><td>sodium azide</td><td>Fluka</td><td>71290</td><td></td></tr><tr><td>bacterial neuraminidase/sialidase</td><td>Sigma-Aldrich</td><td>N6514-1UN</td><td></td></tr></tbody></table>

measuring attachment and internalization of influenza a virus in a549 cells by flow cytometry

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Attachment to target cells followed by internalization are the very first steps of the life cycle of influenza A virus (IAV). We provide here a detailed protocol for measuring relative changes in the amount of viral particles that attach to A549 cells, a human lung epithelial cell line, as well as in the amount of particles that are internalized into the cell. We use biotinylated virus which can be easily detected following staining with Cy3-labeled streptavidin (STV-Cy3). We describe the growth, purification and biotinylation of A/WSN/33, a widely used IAV laboratory strain. Cold-bound biotinylated IAV particles on A549 cells are stained with STV-Cy3 and measured using flow cytometry. To investigate uptake of viral particles, cold-bound virus is allowed to internalize at 37 &#176;C. In order to differentiate between external and internalized viral particles, a blocking step is applied: Free binding spots on the biotin of attached virus on the cell surface are bound by unlabeled streptavidin (STV). Subsequent cell permeabilization and staining with STV-Cy3 then enables detection of internalized viral particles. We present a calculation to determine the relative amount of internalized virus. This assay is suitable to measure effects of drug-treatments or other manipulations on attachment or internalization of IAV.

A cartoon describing the four different experimental conditions is shown in Figure 1. Results of a representative experiment are presented in Figures 2-5. In the “0 min” sample, biotinylated virus is cold-bound to target cells which can be visualized by STV-Cy3 staining (Figures 1 and 2). When a blocking step (in the “0 min + STV” sample) is applied, virus at the cell surface can no longer be detected by STV-Cy3 staining. As a result, th...

We present a protocol describing a semi-quantitative method for measuring both, the attachment of influenza A virus to A549 cells, as well as the internalization of virus particles into the target cells by flow cytometry.

Attachment to target cells followed by internalization are the very first steps of the life cycle of influenza A virus (IAV). We provide here a detailed ...

The overall goal of this procedure is to measure attachment and internalization of influenza. A virus particles into a 5 49 lung epithelial cells. This is accomplished by first cold binding by a ated influenza, a virus to a 5 49 cells, which allows attachment but prevents uptake of viral particles.Next, the virus is allowed to internalize by shifting the temperature to 37 degrees Celsius. Then a blocking step in which unlabeled strp Aden is bound to cell surface. Attached viruses is performed in order to discriminate between attached and internalized viral particles.Finally, the cell associated biotinylated virus is incubated with CY three labeled streptavidin and flow cytometry is used to detect the stained viruses. Ultimately, the relative amount of attached and internalized viruses is calculated. Though this method can provide insight into the relative amount of influenza, a virus that attaches and internalizes into a 5 0 9 cells.It can also be applied to other systems using different cell lines or other viruses After generating biotinylated virus and determining the required amounts of the labeled virus strep din and SI three labeled strep din according to the text protocol, prepare four deep well tubes each containing 200, 000, A 5 49 cells labeled the tubes as zero minutes. Zero minutes, plus STV, 30 minutes and 30 minutes plus STV. Next, spin the tubes.Remove the supernatant and use 200 microliters of PBS to resuspend the pellets. Then after spinning the tubes again, use 200 microliters of a 5 49 standard growth medium to resuspend the cells incubate at 37 degrees Celsius for 30 minutes following the incubation centrifuge the samples and resuspend the pellets in 200 microliters of PBS After repeating the wash one more time, cool the tubes down on ice for 10 minutes. When the tubes have cooled, spin again and use 100 microliters of biotinylated virus diluted in infection PBS to re suspend the pellets after incubating on ice for one hour, repeat the spin and wash with PBS twice, processing the following samples in parallel as much as possible for the zero minute samples.After spinning, use 100 microliters of 3.7%paraform aldehyde or PFA to resuspend the cell pellet. Incubate at room temperature for 10 minutes before spinning and using PBS to wash the cells twice following fixation. Store at four degrees Celsius until all samples have been processed.To treat the zero minute plus STV samples, spin the tubes, remove the supernatant and use 15 microliters of STV 2%BSA and 0.1%sodium azi in PBS to resuspend the cell pellet incubate on ice for 30 minutes. Then centrifuge and use PBS to wash the cells twice after fixation with PFA as just demonstrated door the samples at four degrees Celsius for the 30 minute samples. After spinning and removing the supernat, use PBS 2%BSA to dissolve the samples.Incubate at 37 degrees Celsius for 30 minutes before washing with PBS and fixing with PFA. Then store the samples at four degrees Celsius for the 30 minutes plus STV samples. After pelleting, we suspend the samples in 200 microliters of PBS 2%BSA, following an incubation at 37 degrees Celsius for 30 minutes.Spin and resuspend the cells in 50 microliters of STV 2%BSA 0.1%Sodium azi in PBS incubate on ICE for 30 minutes before washing and fixing. Then after permeable and staining all samples with STV SI three, following the details in the text protocol, stored the samples at four degrees Celsius. Finally, analyze the samples by flow cytometry.Determine the percentage of CY three positive cells in each sample. Calculate the percentage of attached virus and the relative amount of internalized virus. According to the text protocol as shown here in the zero minutes sample, ated virus is cold bound to target cells as visualized by St.V.SI three staining.When STV is applied as a blocking step virus at the cell surface can no longer be detected by S St.V.SI three staining strongly reducing the signal. When the temperature is raised to 37 degrees Celsius, attached virus is taken up into cells. Internalized virus is not sensitive to blocking with unlabeled STV resulting in a less dramatic drop in signal intensity in the 30 minutes plus STV samples shown.Here are the percentages of SI three positive cells for all experimental conditions described in this video. Mock infected cells give the background signal intensity for the experiment and act as a negative control for virus attachment. Another control neuraminidase strongly abrogates IAV attachment by 90%compared to untreated cells.Sodium azi, which depletes a TP, thus inhibiting endocytosis, inhibited the internalization of virus particles both during and after infection, as shown here following sodium azi treatment cells incubated for 30 minutes at 37 degrees Celsius showed a dramatic drop in internalization compared to untreated cells incubated under the same conditions. After watching this video, you should have a good understanding of how to measure attachment and internalization of influenza, a virus in a 5 0 9 cells. This protocol allows for convenient readout by flow cytometry and can be easily adapted to other experimental settings.

measuring-attachment-internalization-influenza-virus-a549-cells-flow

Research

JoVE Journal

Immunology and Infection

We present an in vitro, two-color fluorescence assay to visualize the fusion of single virus particles with a fluid target bilayer. By labeling viral particles with fluorophores that differentially stain the viral membrane and its interior, we are able to monitor the kinetics of hemifusion and pore formation.

Method for Measurement of Viral Fusion Kinetics at the Single Particle Level

This method describes the use of Infrared dye based imaging system for detection of H1N1 in bronchioalveolar lavage (BAL) fluid of infected mice at a high sensitivity. This methodology can be performed in a 96- or 384-well plate, requires &lt;10 μl volume of test material and has the potential for concurrent screening of multiple pathogens.

High-throughput Detection Method for Influenza Virus

We describe the rapid isolation of primary murine type II alveolar epithelial cells (AECII) by flow cytometric negative selection. These AECII show high viability and purity and are suitable for a wide range of functional and molecular studies regarding their role in respiratory conditions such as autoimmune or infectious diseases.

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies

Source: Klaus, J. P., et al Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment. J. Vis. Exp. (2016).This video demonstrates how to measure arenavirus attachment to monkey kidney cells. The assay uses low temperatures to block endocytosis and isolate the virus binding step. The approach enables precise quantification of surface-bound virus particles under conditions that restrict internalization.

An In Vitro Assay to Study Arenavirus Attachment to the Host Cell

In this video, we discuss the correlation between the CIT50 and the multiplicity of viral infections. The virus-infected cells display cytopathic effects, causing their death and detachment from the gold microelectrode, which in turn, reduces the impedance.

Impedance-Based Cellular Assay to Measure Multiplicity of Infection of Influenza Virus

This video demonstrates the bacterial adherence assay to evaluate GFP-tagged bacterial adherence to epithelial cell culture to study the dynamics of host-pathogen interactions using fluorescence microscopy-based imaging.

Detection of Bacterial Adherence to Host Cells Using Fluorescence Imaging

This video demonstrates an assay measuring the antibody-mediated activation of T cell effector functions. Adding an influenza virus hemagglutinin (HA)-specific monoclonal antibody to transfected mammalian cells expressing HA results in the formation of immune complexes with HA. Upon introducing engineered T cells expressing Fc receptors and a luciferase reporter, the T cells are activated by the antibody-HA complexes, and this activation is detected by adding a luciferase substrate and...

Measuring the Activation of Fc-Mediated Effector Functions by HA Antibodies

The first step in the arenavirus life cycle is attachment of viral particles to host cells. We report a quantitative (q)RT-PCR-based assay for ultrasensitive detection and quantitation of arenavirus attachment events.

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment

We describe the enzyme-linked lectin assay (ELLA) for measuring influenza neuraminidase (NA)-inhibition antibody titers in sera. The assay uses peanut agglutinin to quantify galactose residues that become accessible when NA removes sialic acid from fetuin-coated, 96-well plates.

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

We describe a method to measure the activation of Fc-mediated effector functions by antibodies that target the influenza virus hemagglutinin. This assay can also be adapted to assess the ability of monoclonal antibodies or polyclonal sera targeting other viral surface glycoproteins to induce Fc-mediated immunity.

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Reported here is a protocol for the quantification of infectious viral particles using real-time monitoring of electrical impedance of infected cells. A practical application of this method is presented by quantifying influenza A virus decay under different physicochemical parameters mimicking environmental conditions.

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Learn to measure influenza A virus attachment and internalization in A549 lung epithelial cells using flow cytometry. This protocol uses cold binding, temperature shift, and blocking steps to distinguish attached from internalized viral particles.

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Explore More Videos